Logo

GUJARAT TERCE LABORATORIES LTD Share Price

BSE: 524314
|
Pharmaceuticals
₹ 33.90
+₹0.13 (0.38%)
1D
Last updated 03 Jul, 2026, 15:25 IST

GUJARAT TERCE LABORATORIES LTD Share Price Today

As of 5 Jul 2026, GUJARAT TERCE LABORATORIES LTD share price is ₹33.90. The stock opened at ₹34.25, compared to its previous close of ₹33.77. During today's trading session, GUJARAT TERCE LABORATORIES LTD share price moved in the range of ₹32.85 to ₹34.25, with an average price of ₹33.55 for the day. Looking at its last 52-week, the stock has touched a low of ₹29.00 and a high of ₹59.78.

₹32.85
0.38% up today
₹34.25
1D LOW
1D HIGH

GUJARAT TERCE LABORATORIES LTD Returns Calculator

Open
₹34.25
High
₹34.25
Low
₹32.85
Prev. close
₹33.77
Circuit
L
H
₹26.68
₹40.02
52-week
L
H
₹29.00
₹59.78

GUJARAT TERCE LABORATORIES LTD Shareholder Returns

GUJARAT TERCE LABORATORIES LTD Share Price History

Mkt Cap Cr
26.31
P/E
11.93
P/B
2.70
ROE
25.62%
D/E
0.13
ROCE
29.29%
Div. Yield
0.00%
EPS(TTM)
2.92
Turnover
3.49
EV/EBITDA
7.13
Net Margin
0.00%
Op. Margin
0.00%
ROA
9.04%
Quick Ratio
0.00
Curr. Ratio
1.49
Based on fundamentals, this stock's
Step 1 of 5
Performance
Very Poor
Guj. Terce Labs. has not beaten FD return of 7%
Step 3 of 5
Valuation
Fairly Valued
Guj. Terce Labs. appears to be fairly valued compared to its peers
Step 2 of 5
Earnings
Poor
Guj. Terce Labs. earnings have been degrowing
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROED/EROCEBook ValueDiv. YieldTurnoverEPS(TTM)
Sun Pharmaceutical Industries4,49,048.0039.025.3713.74%0.6117.33%93.240.85%0.5610.90
Divis Laboratories1,77,179.0069.0010.5715.32%0.0019.56%629.490.45%0.5898.19
Torrent Pharmaceuticals1,57,804.0066.0317.0326.76%1.0518.30%16.900.90%0.4964.75
Cipla1,17,642.0025.472.8711.79%0.0015.66%2.891.06%0.4943.52
Dr. Reddy's Laboratories1,12,368.0027.032.9711.07%0.1812.54%375.780.59%0.6338.68
Zydus Lifesciences1,10,651.0021.604.0818.59%0.3117.35%235.250.09%0.3935.38
Lupin1,09,676.0020.484.8923.76%0.0424.88%659.050.75%0.61129.18
Mankind Pharma1,02,729.0053.006.3011.74%0.3413.13%397.020.04%0.5449.37
Aurobindo Pharma90,608.0025.872.399.25%0.1911.76%391.140.26%0.4841.58
Laurus Labs82,398.9060.2610.1018.21%0.4516.70%10.190.20%0.9713.72

GUJARAT TERCE LABORATORIES LTD Financials

Full statement

Income Statement · Consolidated

Income Statement · Consolidated — all values in INR Crore
ParticularsMar 2019Mar 2020Mar 2021
Revenue31.3537.8325.98
Operating profit0.350.44-2.53
Net profit0.430.28-2.52

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Revenue₹50.20₹47.97₹46.78₹40.13
Other Income₹0.31₹0.32₹0.35₹0.31
Total Revenue₹50.50₹48.30₹47.14₹40.44
Total Expenses₹47.11₹47.75₹50.03₹39.69
Profit Before Tax₹3.39₹0.54-₹2.89₹0.75
Tax₹4.37₹0.30-₹1.22-₹0.13
Profit After Tax-₹0.98₹0.24-₹1.67₹0.87
EPS - Basic-₹1.32₹1.26-₹2.25₹1.18
EPS - Diluted-₹1.32₹1.26-₹2.25₹1.18

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Profit before tax₹3.39₹0.54-₹2.89₹0.75
Income before WC changes₹3.92₹1.31-₹1.88₹1.34
Change in Assets₹0.40₹3.07-₹0.02-₹3.13
Change in Liabilities-₹1.18-₹1.78₹1.96₹1.44
Change in WC-₹0.78₹1.29₹1.94-₹1.69
Cash flow from Operations₹3.06₹2.60₹0.03-₹0.44
Cash flow from Investing₹0.46-₹0.46₹0.62-₹0.87
Cash flow from Financing-₹2.83-₹4.08-₹0.12₹1.53
Total Cash Flow₹0.69-₹1.94₹0.52₹0.22
Cash (Start of the year)₹0.09₹2.03₹1.51₹1.29
Cash (End of the year)₹0.78₹0.09₹2.03₹1.51

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Non-Current Assets₹10.80₹12.05₹12.48₹11.92
Current Assets₹12.02₹11.22₹16.05₹15.48
Total Assets₹22.83₹23.27₹28.53₹27.39
Current Liabilities₹12.64₹12.14₹16.61₹13.21
Net Current Asset-₹0.62-₹0.92-₹0.56₹2.26
Non-Current Liabilities₹3.71₹4.03₹5.06₹5.64
Equity Capital₹6.48₹7.11₹6.86₹8.53
Total Equity & Liabilities₹22.83₹23.27₹28.53₹27.39
* All values are in INR Crore
Qty
Bid
0
0
0
0
0
0
0
0
0
0
Ask
Qty
33.35
21
0
0
0
0
0
0
0
0
Bid Total: 0
Ask Total: 21
Buy orders: 0%
Sell orders: 100%
Bearish
2
Neutral
3
Bullish
3
Slightly Bullish
by SEBI experts
Expert Pick
EXPPICK
Stop-loss
Entry price
Target
Indicator
Value
Verdict
RSI (14)
44.65
Neutral
ATR (14)
2.38
Neutral
STOCH(9,6)
9.9
Bullish
STOCH RSI (14)
0
Bullish
ADX(9)
30.7
Bearish
UO(9)
35.35
Neutral
ROC(12)
-3.33
Bearish
WillR(14)
-92.59
Bullish
Period
Simple value
Exponential vaue
5D
34.8
34.33
10D
34.73
34.58
20D
34.54
34.68
50D
35.44
35.31
100D
36.7
37.22

About GUJARAT TERCE LABORATORIES LTD

GUJARAT TERCE LABORATORIES LTD logo
ISIN
INE499G01013
Sector Market Cap
₹ 26.31 Cr

Gujarat Terce Laboratories Limited is an India-based integrated pharmaceutical company. The Company is engaged in the development, manufacturing, marketing and distribution of medicines and healthcare products. Its product basket includes branded as well as generic formulations offering solutions for disease prevention and control. It offers a range of products under 52 brands, totaling 135 items approximately, and its portfolio covers 10 therapeutic categories such as respiratory, gynecology, antibiotics, pain therapy, gastrology, nutraceutical, and ayurvedic therapies. The Company’s brands include Acolate, Codimol, Terflora Z, Thyter, Tynol, Moxxil and Vitfol, among others. It caters to both domestic and international markets. The manufacturing facility of the Company is located at Chhatral in Gandhinagar, Gujarat.

GUJARAT TERCE LABORATORIES LTD Financial Highlights

  • Revenue: GUJARAT TERCE LABORATORIES LTD reported revenue of ₹25.98 crore in FY21 vs ₹37.83 crore in FY20. It showed a decrease of 31.32% on a yearly basis.
  • Operating Profit: GUJARAT TERCE LABORATORIES LTD reported an operating loss of ₹2.53 crore in FY21 vs ₹0.44 crore in FY20. It showed a decrease of 675.00% on a year-on-year basis.
  • Net Profit: GUJARAT TERCE LABORATORIES LTD reported a net loss of ₹2.52 crore in FY21 vs ₹0.28 crore in FY20. It showed a decrease of 1,000.00% on a yearly basis.

GUJARAT TERCE LABORATORIES LTD Quarterly Result Highlights

  • GUJARAT TERCE LABORATORIES LTD reported revenue of ₹10.21 crore in Sep 2021, compared with ₹10.01 crore in Jun 2021, representing an increase of 2.00% on a quarter-on-quarter (QoQ) basis.
  • GUJARAT TERCE LABORATORIES LTD reported an operating profit of ₹0.45 crore in Sep 2021, compared with ₹1.60 crore in Jun 2021, representing a decrease of 71.88% on a quarter-on-quarter (QoQ) basis.
  • GUJARAT TERCE LABORATORIES LTD reported a profit of ₹0.45 crore in Sep 2021, compared with ₹1.60 crore in Jun 2021, reflecting a decrease of 71.88% on a QoQ basis.
Know more
Promoters
40.03%
FII
0.00%
Other DII
0.00%
Retail and other
59.97%
Mutual funds
0.00%
Foreign institutions - FII
Compare against other stocks
GUJARAT TERCE LABORATORIES LTD logo
GUJARAT TERCE LABORATORIES LTD
Pharmaceuticals
Add Stock
Add Another

FAQs on GUJARAT TERCE LABORATORIES LTD Share Price